Prevention of Rh Hemolytic Disease — Ten Years' Clinical Experience with Rh Immune Globulin
- 8 May 1975
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 292 (19) , 1014-1016
- https://doi.org/10.1056/nejm197505082921906
Abstract
IN 1960 an Rh Antepartum Clinic was organized at the Columbia–Presbyterian Medical Center to make a more complete and prospective study of the natural history of Rh disease and to apply and evaluate new methods of management and prevention.1 , 2 All mothers at risk —that is, all Rh negative women (both sensitized and non-sensitized) and all other women who have produced an erythroblastotic child — are referred to this clinic. If the husband's blood type is also found to be Rh negative, the patient is managed in the routine Antepartum Clinic. This report is concerned with the change in the profile . . .Keywords
This publication has 9 references indexed in Scilit:
- Results of Clinical Trials of RhoGAM* in WomenTransfusion, 1968
- Prevention of Rh isoimmunization. Progress report of the clinical trial in mothersJAMA, 1967
- Rh Factor: Prevention of Isoimmunization and Clinical Trial on MothersScience, 1966
- PREVENTION OF RHESUS HÆMOLYTIC DISEASEThe Lancet, 1965
- Untersuchungen zur serologischen Prophylaxe der Rh-SensibilisierungAnnals of Hematology, 1965
- ANTEPARTUM MANAGEMENT AND PREVENTION OF Rh ISOIMMUNIZATIONAnnals of the New York Academy of Sciences, 1965
- Successful Prevention of Experimental Rh Sensitization in Man with an Anti‐Rh Gamma2‐Globulin Antibody Preparation: A Preliminary ReportTransfusion, 1964
- Further Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1963
- Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1961